home / stock / mdxg / mdxg short
Short Information | MiMedx Group Inc (OTCMKTS:MDXG)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 1,772,370 |
Total Actual Volume | 3,301,576 |
Short Trends | |
---|---|
Cover Days | 3 |
Short Days | 14 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 88,619 |
Average Short Percentage | 62.17% |
Is there a MDXG Short Squeeze or Breakout about to happen?
See the MDXG Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-03-2020 | $6.35 | $6.56 | $6.72 | $6.28 | 261,058 | 146,400 | 56.08% |
11-02-2020 | $5.5 | $6.1 | $6.67 | $5.5 | 373,630 | 212,803 | 56.96% |
10-30-2020 | $5.75 | $5.32 | $5.94 | $5.32 | 292,928 | 181,183 | 61.85% |
10-29-2020 | $5.8 | $5.75 | $5.99 | $5.53 | 288,548 | 167,721 | 58.13% |
10-28-2020 | $5.79 | $5.8 | $6.04 | $5.78 | 93,054 | 54,354 | 58.41% |
10-27-2020 | $5.85 | $5.84 | $6 | $5.8 | 52,636 | 32,583 | 61.9% |
10-26-2020 | $6 | $5.91 | $6.05 | $5.85 | 91,606 | 48,970 | 53.46% |
10-23-2020 | $6.37 | $5.86 | $6.37 | $5.52 | 242,793 | 122,329 | 50.38% |
10-22-2020 | $6.4245 | $6.38 | $6.45 | $6.32 | 635,430 | 318,789 | 50.17% |
10-21-2020 | $6.42 | $6.41 | $6.49 | $6.4 | 42,425 | 24,861 | 58.6% |
10-20-2020 | $6.41 | $6.47 | $6.5 | $6.4 | 16,885 | 7,322 | 43.36% |
10-19-2020 | $6.6 | $6.6 | $6.6599 | $6.49 | 14,696 | 39,997 | 272.16% |
10-16-2020 | $6.58 | $6.52 | $6.67 | $6.45 | 155,698 | 46,318 | 29.75% |
10-15-2020 | $6.57 | $6.59 | $6.62 | $6.5 | 67,527 | 16,376 | 24.25% |
10-14-2020 | $6.63 | $6.58 | $6.72 | $6.55 | 98,456 | 55,216 | 56.08% |
10-13-2020 | $6.66 | $6.74 | $6.74 | $6.56 | 44,445 | 20,273 | 45.61% |
10-12-2020 | $6.69 | $6.71 | $6.74 | $6.4 | 104,800 | 46,632 | 44.5% |
10-09-2020 | $6.52 | $6.68 | $6.74 | $6.52 | 183,190 | 115,480 | 63.04% |
10-08-2020 | $6.55 | $6.61 | $6.74 | $6.4 | 108,321 | 73,503 | 67.86% |
10-07-2020 | $6.59 | $6.5 | $6.62 | $6.46 | 133,450 | 41,260 | 30.92% |
News, Short Squeeze, Breakout and More Instantly...
Receives Determination Letter from FDA Stating AXIOFILL Does Not Qualify for Classification as an HCT/P Under Section 361 MIMEDX Continues to Pursue All Available Options to Keep AXIOFILL on the Market Reiterates Expectations for 2024 Net Sales Percentage Growth in the Low Doubl...
MARIETTA, Ga., March 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has entered into an agreement with TELA Bio, Inc. to obtain exclusive rights to its manufacturing and supply agreement with Regenity ...
2024-03-14 02:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...